New action plan to support SMEs as drivers of pharmaceutical innovation

16 actions identified for implementation in 2017-2020

The European Medicines Agency (EMA) has published today an action plan for small and medium-sized enterprises (SMEs), which aims to foster innovation and support SMEs in the development of novel human and veterinary medicines.

SMEs are the backbone of Europe's economy. They represent 99% of all businesses in the European Union (EU) and provide two-thirds of total private sector employment. In the pharmaceutical sector SMEs are a motor of innovation and play a major role in the development of new medicines.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /